| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.02▼ | 7.05▼ | 7.05▼ | 7.10▼ | 8.03▼ |
| MA10 | 7.02▼ | 7.07▼ | 7.06▼ | 7.15▼ | 9.16▼ |
| MA20 | 7.05▼ | 7.07▼ | 7.05▼ | 7.83▼ | 8.83▼ |
| MA50 | 7.07▼ | 7.14▼ | 7.17▼ | 9.10▼ | 6.45▲ |
| MA100 | 7.09▼ | 7.21▼ | 7.22▼ | 8.58▼ | 7.11▼ |
| MA200 | 7.15▼ | 7.37▼ | 8.55▼ | 6.87▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.000▲ | 0.001▲ | -0.009▼ | -0.442▼ |
| RSI | 40.842▼ | 44.802▼ | 44.174▼ | 33.661▼ | 44.551▼ |
| STOCH | 15.575▼ | 23.031 | 41.493 | 35.272 | 23.396 |
| WILL %R | -90.000▼ | -67.708 | -67.708 | -77.095▼ | -92.743▼ |
| CCI | -28.508 | -80.235 | -105.955▼ | -61.381 | -154.703▼ |
| CDL | $ENGN Doji Candlestick Pattern Detected | Set Alert |
|
Sunday, March 15, 2026 02:53 PM
Executives from enGene (NASDAQ:ENGN) provided an update on the company’s detalimogene program in non-muscle invasive bladder cancer (NMIBC), discussing recent protocol changes, regulatory interactions ...
|
|
Sunday, March 15, 2026 01:57 PM
CEO Ron Cooper said the company’s focus is advancing its DDX platform, a proprietary non-viral gene therapy technology, with its lead program detalimogene being developed for non-muscle invasive ...
|
|
Sunday, March 15, 2026 12:19 PM
Chief Executive Officer Ron Cooper used a presentation at the Citizens Life Sciences Conference to outline the company’s approach to non-muscle invasive bladder cancer (NMIBC), emphasizing both the un ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/03/26 | 7.01 | 7.335 | 6.855 | 7.01 | 107,566 |
| 25/03/26 | 6.94 | 7.30 | 6.94 | 7.07 | 114,313 |
| 24/03/26 | 7.20 | 7.33 | 6.71 | 6.90 | 145,689 |
| 23/03/26 | 7.22 | 7.50 | 6.915 | 7.31 | 143,255 |
| 20/03/26 | 7.19 | 7.48 | 7.10 | 7.21 | 193,064 |
| 19/03/26 | 7.04 | 7.24 | 6.95 | 7.215 | 149,494 |
| 18/03/26 | 7.10 | 7.47 | 6.9101 | 7.18 | 1,084,742 |
| 17/03/26 | 7.27 | 7.92 | 7.24 | 7.25 | 516,620 |
| 16/03/26 | 7.28 | 7.54 | 6.99 | 7.23 | 372,095 |
| 13/03/26 | 7.38 | 7.43 | 6.94 | 7.16 | 791,266 |
|
|
||||
|
|
||||
|
|